PLUS1
10.10
-0.27 (-2.6%)
-0.27 (-2.6%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 511,214 |
|
|||||
| News | - | ||||||
| Day High | 10.545 | Low High |
|||||
| Day Low | 9.95 | ||||||
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
USA Small Cap Basic
Monthly Subscription
for only
|
|
USA Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Aclaris Therapeutics Inc | ACRS | NASDAQ | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade
 |
|
|---|---|---|---|---|
| -0.27 | -2.6% | 10.10 | 12:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 10.47 | 9.95 | 10.545 | 10.10 | 10.37 |
| Trades | Stocks Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,702 | 511,214 | US$ 10.21 | US$ 5,221,980 | - | 9.26 - 30.375 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:05:16 | 1 | US$ 10.11 | USD |
Period:
Draw Mode:
Aclaris Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 618.40M | 61.23M | 52.14M | US$ 6.48M | US$ - | -1.20 | -6.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | US$ - | - | -1.96M | 4.00% |
Aclaris Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 20/1/2022 | 00:26 | TipRanks | Jefferies Thinks Aclaris Therapeutics’ Stock is Going to.. |
| 15/1/2022 | 09:01 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 12/1/2022 | 08:45 | Seeking Alpha | Aclaris falls on the exit of medical chief |
| 12/1/2022 | 08:01 | GlobeNewswire Inc. | Aclaris Therapeutics Provides R&D Update |
| 06/1/2022 | 08:35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 27/12/2021 | 23:00 | GlobeNewswire Inc. | Aclaris Therapeutics to Participate in the H.C. Wainwright.. |
| 21/12/2021 | 18:11 | TipRanks | H.C. Wainwright Reaffirms Their Buy Rating on Aclaris.. |
| 09/12/2021 | 18:38 | TipRanks | Leerink Partners Reiterates a Buy Rating on Aclaris.. |
| 07/12/2021 | 23:03 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 04/12/2021 | 08:53 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 03/12/2021 | 23:00 | GlobeNewswire Inc. | Aclaris Therapeutics Announces Publication of Preclinical.. |
| 19/11/2021 | 08:01 | GlobeNewswire Inc. | Aclaris Therapeutics to Host Virtual R&D Day on December 7,.. |
Historical ACRS Price Data
| Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 10.16 | 10.87 | 9.26 | 10.15 | 470,757 | -0.06 | -0.59% |
| 1 Month | 14.51 | 15.11 | 9.26 | 11.69 | 524,676 | -4.41 | -30.39% |
| 3 Months | 16.16 | 17.22 | 9.26 | 13.03 | 431,384 | -6.06 | -37.5% |
| 6 Months | 15.05 | 19.97 | 9.26 | 14.97 | 423,572 | -4.95 | -32.89% |
| 1 Year | 17.06 | 30.375 | 9.26 | 19.18 | 606,169 | -6.96 | -40.8% |
| 3 Years | 6.69 | 30.375 | 0.70 | 9.75 | 886,593 | 3.41 | 50.97% |
| 5 Years | 26.90 | 33.25 | 0.70 | 11.61 | 662,653 | -16.80 | -62.45% |
